Shanmuga Hospital Limited Announces Strategic Growth and Commitment to Quality Healthcare

Salem (Tamil Nadu) [India], February 11:  Shanmuga Hospital Limited, a leading multispecialty healthcare provider in Salem, proudly reaffirms its commitment to providing high-quality medical care as it embarks on its next phase of growth. With 151 beds and state-of-the-art medical facilities, the hospital continues to enhance its services to meet the growing healthcare needs of the region.

As a NABH and NABL-accredited institution, Shanmuga Hospital is dedicated to excellence in patient care, offering specialized treatments in oncology, neurology, cardiology, and more. The hospital is also empaneled with various government agencies and insurance providers, ensuring accessible and affordable treatment for a wider community.

Speaking on the occasion, Dr. Panneerselvam Palaniappan Shanmugam, Managing Director, Shanmuga Hospital Limited, said:

“Our journey has always been about putting patients first. With advanced medical technologies and a dedicated team of professionals, we strive to set new benchmarks in healthcare. This expansion aligns with our vision to provide comprehensive, affordable, and quality medical services. We remain committed to innovation, efficiency, and enhancing patient experiences.”

The hospital recently announced its upcoming Initial Public Offering (IPO), opening on February 13, 2025, and closing on February 17, 2025, on the BSE SME platform. The IPO aims to support capital expenditure for acquiring cutting-edge medical equipment and strengthening the hospital’s infrastructure.

With a strong legacy in healthcare and a patient-centric approach, Shanmuga Hospital Limited is poised for continued success, reinforcing its role as a trusted healthcare partner in Tamil Nadu.

For media inquiries, please contact:

Vikrm B Sanass

Director

ICon PR and Media

If you have any objection to this press release content, kindly contact [email protected] to notify us. We will respond and rectify the situation in the next 24 hours.

Business

Fischer Medical Subsidiary, Time Medical India, Collaborates with Dr. Cherian to Pioneer Next-Generation AI-Enabled MRI System

Mumbai (Maharashtra) [India], November 4: Fischer Medical Ventures Limited (FISCHER | 524743 | INE771F01041), Time Medical International Ventures (I) P LTD, the wholly owned subsidiary of Fischer Medical Ventures Limited, today announced a strategic collaboration with globally acclaimed neurosurgeon, educator, and innovator Dr Iype Cherian. The collaboration’s sole purpose is the development of DRIS–iMRI Medharanya, a […]

Read More
Agartala Business Dr. Saikat Kar innovation Neurotech Startup Science

From Agartala to Global Innovation: How Tripura’s First Neurotech Startup is Bridging Brain Science with Grassroots Impact

Agartala (Tripura) [India], November 4: In a region celebrated for tea gardens and handicrafts rather than technological ambition, a quiet revolution is unfolding. Codonmind Nexus Private Limited, the Northeast’s pioneering neurotechnology startup, is developing brain-computer interface devices and advanced neurological research tools positioned to compete with national players in a market projected to reach USD […]

Read More
Business Harsheep Hortico Limited

Harshdeep Hortico Reports Strong H1 FY26 with Net Profit of INR 5.7 crore

Mumbai (Maharashtra) [India], November 4: Harsheep Hortico Limited (BSE: HARSHDEEP), specializing in the manufacture and export of pots, planters, garden accessories, and outdoor furniture; announced its Unaudited financials for H1 FY26. Key H1 FY25 Financial Highlights Key Financial Highlights (Consolidated) – H1 FY2025-26 Revenue for H1 FY2025–26 was ₹37.84 crore, compared to ₹24.09 crore in […]

Read More